|

Daratumumab Injection Clinical Trials

3 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: Darzalex

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • University of Maryland, Baltimore1
  • Tata Memorial Centre1
  • Stichting Hemato-Oncologie voor Volwassenen Nederland1

Indications

  • Cancer3
  • T Acute Lymphoblastic Leukemia1
  • Plasma Cell Disorder1
  • Multiple Myeloma1

Other2 trials

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Phase 3
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
Phase 2

Baltimore, Maryland1 trial

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

University of Maryland Greenebaum Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.